Psoriasis Clinical Trial
Long-Term Safety and Efficacy of Imsidolimab (ANB019) in Subjects With Generalized Pustular Psoriasis
Summary
This is a Phase 3, long term extension study to evaluate the safety and efficacy of imsidolimab compared with placebo in adult subjects with generalized pustular psoriasis (GPP).
Full Description
This study will also evaluate the pharmacokinetic (PK) profile of imsidolimab and explore the immunogenicity of imsidolimab in subjects with GPP
Eligibility Criteria
Inclusion Criteria:
Subject participated in the preceding placebo-controlled Phase 3 study ANB019-301 and completed at least the Week 1 visit of the ANB019-301 study without the use of rescue/prohibited medication for GPP
Subject must be a candidate for prolonged GPP treatment according to the Investigator's judgment
Exclusion Criteria:
Use of prohibited medications between the last visit of the ANB019-301 study and the Day 1 visit of the ANB019-302 study.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 5 Locations for this study
Largo Florida, 33771, United States
Louisville Kentucky, 40056, United States
Ann Arbor Michigan, 48108, United States
Ann Arbor Michigan, 48108, United States
Dallas Texas, 75061, United States
Springville Utah, 84663, United States
Melbourne , , Australia
Sydney , , Australia
Nantes , , France
Paris , , France
Batumi , , Georgia
Tbilisi , , Georgia
Tbilisi , , Georgia
Tbilisi , , Georgia
Tbilisi , , Georgia
Bensheim , , Germany
Bonn , , Germany
Hanau , , Germany
Würzburg , , Germany
Pusan , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Cheras , , Malaysia
Johor Bahru , , Malaysia
Johor Bahru , , Malaysia
Kota Bharu , , Malaysia
Kuala Lumpur , , Malaysia
Kuala Lumpur , , Malaysia
Muar , , Malaysia
Pulau Pinang , , Malaysia
Putrajaya , , Malaysia
Selayang Baru Utara , , Malaysia
Casablanca , , Morocco
Casablanca , , Morocco
Oujda , , Morocco
Kraków , , Poland
Ossy , , Poland
Rzeszów , , Poland
Wrocław , , Poland
Łódź , , Poland
Bucuresti , , Romania
Cluj-Napoca , , Romania
Iaşi , , Romania
Barcelona , , Spain
Las Palmas De Gran Canaria , , Spain
Madrid , , Spain
Madrid , , Spain
Valencia , , Spain
Kaohsiung , , Taiwan
Taipei , , Taiwan
Taipei , , Taiwan
Taipei , , Taiwan
Bangkok , , Thailand
Chiang Mai , , Thailand
Khon Kaen , , Thailand
Pathum Thani , , Thailand
Sfax , , Tunisia
Sousse , , Tunisia
Tunis , , Tunisia
Ankara , , Turkey
Antalya , , Turkey
Istanbul , , Turkey
Istanbul , , Turkey
Istanbul , , Turkey
Kayseri , , Turkey
Nilüfer , , Turkey
How clear is this clinincal trial information?